Skip to content

Shares (Diluted) at other companies

United Therapeutics logo
United TherapeuticsUTHR
47.2M-2.9%
Rein Therapeutics, Inc. Common Stock logo
Rein Therapeutics, Inc. Common StockRNTX
30.4M+38.5%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
105.5M+48.5%
Design Therapeutics, Inc. logo
Design Therapeutics, Inc.DSGN
61.4M+8.2%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
88.3M+2.4%
CTO
Citius Oncology, Inc.CTOR
100M+39.8%

Other financials

Income statement

See full
Revenue-
Operating income-$11.4M+27.5%
Net income-$10.8M+27.5%
EPS (diluted)-$0.11+35.3%

Balance sheet

See full
Cash & equivalents$10.0M-3.4%
Total debt$12.3M-9.2%
Total equity$57.9M-22.8%
Total assets$79.7M-18.1%

Cash flow

See full
Operating cash flow-$12.5M+18.8%
CapEx$138.0K
Free cash flow-$12.7M+17.9%

Valuation

See full
Market cap$1.14B+30.5%
Enterprise value$1.15B
P/S6,014.3×

Profitability

See full
Operating margin-40,856.3%+28,833pp
Net margin-39,009.5%+29,653pp
FCF margin-32,664.7%+4,018pp

Returns & leverage

See full
Return on equity-105.3%+50.6pp
Debt / equity0.2×0.0×
Current ratio5.8×-2.0×

Where this comes from

Reported directly by Ethos Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Ethos Technologies, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ethos Technologies, Inc. 's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ethos Technologies, Inc. 's shares (diluted)?
Ethos Technologies, Inc. (LIFE) reported shares (diluted) of 98M in Q1 2026.
How has Ethos Technologies, Inc. 's shares (diluted) changed year-over-year?
Ethos Technologies, Inc. 's shares (diluted) increased by 13.4% year-over-year, from 86.5M to 98M.
What is the long-term trend for Ethos Technologies, Inc. 's shares (diluted)?
Over 4 years (2021 to 2025), Ethos Technologies, Inc. 's shares (diluted) has grown at a 52.7% compound annual growth rate (CAGR), from 67.5M to 366.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.